See more : Modipon Limited (MODIPON.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Mednow Inc. (MDNWF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mednow Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Sir Shadi Lal Enterprises Limited (SSLEL.BO) Income Statement Analysis – Financial Results
- 890 5th Avenue Partners, Inc. (ENFAU) Income Statement Analysis – Financial Results
- First Graphene Limited (M11.F) Income Statement Analysis – Financial Results
- XLR Medical Corp. (XLRM) Income Statement Analysis – Financial Results
- Oji Holdings Corporation (3861.T) Income Statement Analysis – Financial Results
Mednow Inc. (MDNWF)
About Mednow Inc.
Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. It also owns and operates retail pharmacies located in British Columbia, Manitoba, Ontario, and Nova Scotia. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
| Metric | 2022 | 2021 | 2020 |
|---|---|---|---|
| Revenue | 16.64M | 414.00K | 0.00 |
| Cost of Revenue | 13.86M | 0.00 | 0.00 |
| Gross Profit | 2.78M | 414.00K | 0.00 |
| Gross Profit Ratio | 16.73% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 19.84M | 8.31M | 385.94K |
| Selling & Marketing | 2.82M | 896.51K | 83.56K |
| SG&A | 22.66M | 9.21M | 469.50K |
| Other Expenses | -19.88M | 0.00 | 0.00 |
| Operating Expenses | 2.78M | 9.41M | 469.50K |
| Cost & Expenses | 36.33M | 9.41M | 469.50K |
| Interest Income | 158.35K | 50.09K | 0.00 |
| Interest Expense | 188.51K | 815.00 | 0.00 |
| Depreciation & Amortization | 1.76M | 201.35K | 206.30K |
| EBITDA | -19.85M | -8.75M | -469.50K |
| EBITDA Ratio | -119.28% | -2,113.93% | 0.00% |
| Operating Income | -19.69M | -8.95M | -469.50K |
| Operating Income Ratio | -118.33% | -2,162.57% | 0.00% |
| Total Other Income/Expenses | -10.38M | -156.60K | 0.00 |
| Income Before Tax | -30.07M | -8.95M | -469.50K |
| Income Before Tax Ratio | -180.73% | -2,162.76% | 0.00% |
| Income Tax Expense | -515.96K | -3.71K | 0.00 |
| Net Income | -29.48M | -8.95M | -469.50K |
| Net Income Ratio | -177.20% | -2,162.76% | 0.00% |
| EPS | -1.37 | -0.49 | -0.02 |
| EPS Diluted | -1.37 | -0.49 | -0.02 |
| Weighted Avg Shares Out | 21.57M | 18.40M | 21.60M |
| Weighted Avg Shares Out (Dil) | 21.57M | 18.40M | 21.60M |
Mednow to Present at Gravitas' 3rd Los Angeles Summit
Mednow partners with Curv Health to offer virtual integrated diabetes management program
Source: https://incomestatements.info
Category: Stock Reports